156 related articles for article (PubMed ID: 33885579)
1. Design, synthesis, and evaluation of positron emission tomography/fluorescence dual imaging probes for targeting facilitated glucose transporter 1 (GLUT1).
Yuen R; Wagner M; Richter S; Dufour J; Wuest M; West FG; Wuest F
Org Biomol Chem; 2021 Apr; 19(14):3241-3254. PubMed ID: 33885579
[TBL] [Abstract][Full Text] [Related]
2. Molecular Imaging of GLUT1 and GLUT5 in Breast Cancer: A Multitracer Positron Emission Tomography Imaging Study in Mice.
Wuest M; Hamann I; Bouvet V; Glubrecht D; Marshall A; Trayner B; Soueidan OM; Krys D; Wagner M; Cheeseman C; West F; Wuest F
Mol Pharmacol; 2018 Feb; 93(2):79-89. PubMed ID: 29142019
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia.
Hamann I; Krys D; Glubrecht D; Bouvet V; Marshall A; Vos L; Mackey JR; Wuest M; Wuest F
FASEB J; 2018 Sep; 32(9):5104-5118. PubMed ID: 29913554
[TBL] [Abstract][Full Text] [Related]
4. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
[TBL] [Abstract][Full Text] [Related]
5. Positherapy: targeted nuclear therapy of breast cancer with 18F-2-deoxy-2-fluoro-D-glucose.
Moadel RM; Weldon RH; Katz EB; Lu P; Mani J; Stahl M; Blaufox MD; Pestell RG; Charron MJ; Dadachova E
Cancer Res; 2005 Feb; 65(3):698-702. PubMed ID: 15705862
[TBL] [Abstract][Full Text] [Related]
6. Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer.
Usuda K; Sagawa M; Aikawa H; Ueno M; Tanaka M; Machida Y; Zhao XT; Ueda Y; Higashi K; Sakuma T
Gen Thorac Cardiovasc Surg; 2010 Aug; 58(8):405-10. PubMed ID: 20703861
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer.
Izuishi K; Yamamoto Y; Mori H; Kameyama R; Fujihara S; Masaki T; Suzuki Y
Oncol Rep; 2014 Feb; 31(2):701-6. PubMed ID: 24297035
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous fluorescence and positron emission tomography for in vivo imaging of small animals.
Zhang B; Liu S; Liu F; Zhang X; Xu Y; Luo J; Shan B; Bai J
J Biomed Opt; 2011 Dec; 16(12):120511. PubMed ID: 22191913
[TBL] [Abstract][Full Text] [Related]
9. The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
Cheong SJ; Lee CM; Kim EM; Lim ST; Sohn MH; Jeong HJ
Nucl Med Biol; 2015 Feb; 42(2):85-91. PubMed ID: 25441255
[TBL] [Abstract][Full Text] [Related]
10. Caged [(18)F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission Tomography.
Flavell RR; Truillet C; Regan MK; Ganguly T; Blecha JE; Kurhanewicz J; VanBrocklin HF; Keshari KR; Chang CJ; Evans MJ; Wilson DM
Bioconjug Chem; 2016 Jan; 27(1):170-8. PubMed ID: 26649808
[TBL] [Abstract][Full Text] [Related]
11. A Novel PET Probe for Brown Adipose Tissue Imaging in Rodents.
Wang H; Wang M; Chansaenpak K; Liu Y; Yuan H; Xie J; Yin H; Branca RT; Li Z; Wu Z
Mol Imaging Biol; 2020 Jun; 22(3):675-684. PubMed ID: 31520279
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. Dynamic 2-Deoxy-2-[
Kristian A; Holtedahl JE; Torheim T; Futsaether C; Hernes E; Engebraaten O; Mælandsmo GM; Malinen E
Mol Imaging Biol; 2017 Apr; 19(2):271-279. PubMed ID: 27541026
[TBL] [Abstract][Full Text] [Related]
14. Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma.
Thézé B; Bernards N; Beynel A; Bouet S; Kuhnast B; Buvat I; Tavitian B; Boisgard R
BMC Cancer; 2015 Jul; 15():534. PubMed ID: 26198000
[TBL] [Abstract][Full Text] [Related]
15. Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.
Kaira K; Endo M; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Tsuya A; Nakamura Y; Naito T; Hayashi I; Serizawa M; Koh Y; Hanaoka H; Tominaga H; Oriuchi N; Kondo H; Nakajima T; Yamamoto N
J Clin Oncol; 2010 Aug; 28(23):3746-53. PubMed ID: 20625125
[TBL] [Abstract][Full Text] [Related]
16. ¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.
Hong R; Lim SC
World J Gastroenterol; 2012 Jan; 18(2):168-74. PubMed ID: 22253523
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of ¹⁸F-labeled fluoropropyl tryptophan analogs as potential PET probes for tumor imaging.
Chiotellis A; Mu L; Müller A; Selivanova SV; Keller C; Schibli R; Krämer SD; Ametamey SM
Eur J Med Chem; 2013; 70():768-80. PubMed ID: 24239624
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Bioevaluation of Novel [
Yang X; Wang F; Zhu H; Yang Z; Chu T
Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298
[TBL] [Abstract][Full Text] [Related]
19. Influx rate of
Pitman KE; Alluri SR; Kristian A; Aarnes EK; Lyng H; Riss PJ; Malinen E
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2190-2198. PubMed ID: 31264167
[TBL] [Abstract][Full Text] [Related]
20. GLUT1 expression in high-risk prostate cancer: correlation with
Meziou S; Ringuette Goulet C; Hovington H; Lefebvre V; Lavallée É; Bergeron M; Brisson H; Champagne A; Neveu B; Lacombe D; Beauregard JM; Buteau FA; Riopel J; Pouliot F
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):441-448. PubMed ID: 31932660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
